PTD802 is a selective inhibitor of the GPR17 receptor and is made to restore myelin, a process known as remyelination, in ...

Researchers at the University of Colorado Anschutz Medical Campus have uncovered a promising breakthrough in the <a ...

Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...

A promising new treatment accelerates myelin repair, potentially restoring vision and improving brain function in people with ...

A theatre professional who turned to pottery as a form of therapy when she became ill is now supplying top restaurants with ...

Researchers at the University of Colorado Anschutz Medical Campus discovered LL-341070, a drug that restores vision in ...

The drug LL-341070 appears to speed up this repair, improving how well the brain functions, particularly in areas related to ...

Researchers at the University of Colorado Anschutz Medical Campus found a promising therapeutic candidate that could aid in the restoration of vision in those s ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women.

Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...

Researchers have found a promising drug candidate that could help restore vision in individuals with multiple sclerosis (MS) and other neurological conditions that damage neurons.

Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies, including gene elimination, gene ...